Peter Rands
Peter Rands

CEO, Founder

Peter is a qualified patent attorney in the UK and Europe with over 10 years’ experience in the pharmaceutical industry and has always had a passion for pharmaceutical innovation. He graduated from the University of Oxford in 2003 with a first class degree in Chemistry, following which he trained and qualified as a UK and European patent attorney specializing in pharmaceuticals.

In 2008, he joined Teva Pharmaceutical, a generic drug company, to work directly with pharmaceutical formulation teams but left in 2011 to return to private practice with AmLaw 100 firm Mintz Levin, where he advised start-up and mid-cap innovative pharma firms on IP and legal matters. 

Peter left Mintz Levin in 2015 to set up Small Pharma.

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: